• LAST PRICE
    0.4500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.4300/ 1
  • Ask / Lots
    0.6444/ 1
  • Open / Previous Close
    0.0000 / 0.4500
  • Day Range
    ---
  • 52 Week Range
    Low 0.4260
    High 2.6550
  • Volume
    1
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table
TimeVolumeTOI
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTOI
Oncology Institute Inc
33.5M
-0.6x
---
United StatesNUTX
Nutex Health Inc
26.8M
-0.6x
---
United StatesXGN
Exagen Inc
34.1M
-1.8x
---
United StatesAMWL
American Well Corp
116.0M
-0.3x
---
United StatesBBAL
New York Health Care Inc
38.9M
0.0x
---
United StatesROIX
Response Oncology Inc
10.0
0.0x
---
As of 2024-06-17

Company Information

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Contact Information

Headquarters
18000 Studebaker Rd, Suite 800CERRITOS, CA, United States 90703
Phone
562-735-3226
Fax
302-636-5454

Executives

Independent Chairman of the Board
Richard Barasch
Chief Executive Officer, Director
Daniel Virnich
Independent Vice Chairman of the Board
Brad Hively
Chief Financial Officer
Mihir Shah
Chief Operating Officer
Jeremy Castle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$33.5M
Revenue (TTM)
$342.7M
Shares Outstanding
74.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.65
EPS
$-0.81
Book Value
$0.77
P/E Ratio
-0.6x
Price/Sales (TTM)
0.1
Price/Cash Flow (TTM)
---
Operating Margin
-18.13%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.